Luye Pharma Group Ltd.
OTC: LYPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Dian Bo Liu
- Employees
- 5,150
- Headquarters
- Yantai, China
- IPO year
- 2021
- Market cap
- $815.3M
- Website
- https://www.luye.cn
Loading LYPHF…
Loading profile data…Frequently asked questions about LYPHF
What does Luye Pharma Group Ltd. (LYPHF) do?
Luye Pharma Group Ltd., serving as an investment holding company, engages in the global research, development, production, commercialization, and distribution of a diverse portfolio of pharmaceutical products. Their oncology treatments include Lipusu, indicated for ovarian and breast cancer; CMNa, a chemical sensitizer used in cancer radiotherap...
Where does LYPHF trade?
Luye Pharma Group Ltd. (LYPHF) trades on the Other OTC.
What sector is LYPHF in?
Luye Pharma Group Ltd. (LYPHF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Luye Pharma Group Ltd.?
Dian Bo Liu is the chief executive officer of Luye Pharma Group Ltd. (LYPHF).
Where is Luye Pharma Group Ltd. headquartered?
Luye Pharma Group Ltd. is headquartered in China.
Does LYPHF pay a dividend?
Luye Pharma Group Ltd. (LYPHF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LYPHF go public?
Luye Pharma Group Ltd. (LYPHF) completed its initial public offering in 2021.